BOBO DONALD E JR 4: 24,000 shares of EW ($2,012,076)

Our Take

→Bobo's $2M sale represents roughly 3% of his disclosed holdings, a measured reduction rather than a panic dump—the kind of trimming executives do for diversification or life events rather than conviction shifts. For Edwards Lifesciences, which has spent the last two years rebuilding investor confidence after the Sapien 3 transcatheter aortic valve stumbled in clinical data, insider selling at this scale shouldn't trigger alarm. What matters more is the pattern: if we start seeing heavy selling from other executives or board members, that would suggest management has lost faith in the turnaround trajectory.